Why DELFI Diagnostics’ New York approval could shake up the lung cancer screening market
DELFI Diagnostics can now offer FirstLook Lung in all 50 states. Find out what this means for blood-based cancer screening.
What FDA clearance means for Median Technologies eyonis LCS in a crowded AI radiology market
Median Technologies advances eyonis LCS after FDA clearance. Discover what this means for AI lung cancer screening and European expansion.